Structural insight for imidazopyridazines as malarial kinase PfPK7 inhibitors using QSAR techniques

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 636-648

  Sahu, Nitendra K ^a   Kohli, D V ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Antimalarial agents; Docking; Imidazopyridazines; KNN MFA; MLR; PfPK7; QSAR

Indexed keywords

ALANINE; AMINO ACID; ANTIMALARIAL AGENT; ASPARAGINE; ASPARTIC ACID; ENZYME INHIBITOR; GLUTAMINE; IMIDAZOPYRIDAZINE; LEUCINE; LYSINE; METHIONINE; PROTEIN PFPK7; PYRIDAZINE DERIVATIVE; SERINE; TYROSINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; MOLECULAR DOCKING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BINDING SITES; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR STRUCTURE; PROTOZOAN PROTEINS; PYRIDAZINES; PYRIDINES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84863767643     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216300     Document Type: Article

References (36)

1. World Malaria Report, 2008, WHO, Geneva, Switzerland.
2. Gelb, M. H.; Van Voorhis, W. C.; Buckner, F. S.; Yokoyama, K.; Eastman, R.; Carpenter, E. P.; Panethymitaki, C.; Brown, K. A.; Smith, D. F. Mol. Biochem. Parasitol., 2003, 126, 155-163.
3. Sahu, N. K.; Sahu, S.; Kohli, D. V. Novel molecular targets for antimalarial drug development. Chem. Biol. Drug Des., 2008, 71, 287-297.
4. Bouloc, N.; Jonathan, M.; Large, E. S.; David, W.; Keith, H.; Ansell, C. D.; Justin, S. B. Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7. Bioorg. Med. Chem. Lett., 2008, 18, 5294-5298.
5. Merckx, A.; Echalier, A.; Langford, K.; Sicard, A.; Langsley, G.; Joore, J.; Doerig, C.; Noble, M. Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. Structure, 2008, 16, 228-238.
6. Dorin, D.; Semblat, J. P.; Poullet, P.; Alano, P.; Goldring, J. P.; Whittle, C.; Patterson, S.; Chakrabarti, D.; Doerig, C. PfPK7, an atypical MEK-related protein kinase, reflects the absence of classical three-component MAPK pathways in the human malaria parasite Plasmodium falciparum. Mol. Microbiol., 2005, 55, 184-196.
7. Agrawal, V. K.; Srivastava, R.; Khadikar, P. V. QSAR studies on some antimalarial sulfonamides. Bioorg. Med. Chem., 2001, 9, 287-293.
8. Xue, C. X.; Cui, S. Y.; Liu, M. C.; Hu, Z. D.; Fan, B. T. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA. Eur. J. Med. Chem., 2004, 39, 745-753.
9. Zahouily, M.; Lazar, M.; Elmakssoudi, A.; Rakik, J.; Elaychi, S.; Rayadh, A. QSAR for anti-malarial activity of 2-aziridinyl and 2, 3-bis (aziridinyl)-1, 4-naphthoquinonyl sulfonate and acylate derivatives. J. Mol. Model., 2006, 12, 398-405.
10. Srivastava, M.; Singh, H.; Naik, P. K. Quantitative structureactivity relationship (QSAR) of artemisinin: the development of predictive in vivo antimalarial activity models. J. Chemometrics, 2009, 23, 618-635.
11. Ojha, P. K.; Roy, K. Exploring molecular docking and QSAR studies of plasmepsin-II inhibitor di-tertiary amines as potential antimalarial compounds. Mol. Simul., 2011, 37, 779-803.
12. Ojha, P. K.; Roy, K. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors. Med. Chem., 2011, 7, 173-199.
13. Desai, K. R.; Shaikh, M. S.; Coutinho, E. C. Molecular modeling studies, synthesis and biological evaluation of derivatives of Nphenylbenzamide as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors. Med. Chem. Res., 2011, 20, 321-332.
14. Hocart, S. J.; Liu, H.; Deng, H.; De, D., Krogstad, F. M.; Krogstad, D. J. 4-Aminoquinolines active against chloroquine-resistant Plasmodium falciparum: Basis of antiparasite activity and quantitative structure-activity relationship analyses. Antimicrob. Agents Chemother., 2011, 55, 2233-2244.
15. Cormanich, R. A.; Freitas, M. P.; Rittner, R. 2D chemical drawings correlate to bioactivities: MIA-QSAR modelling of antimalarial activities of 2, 5-diaminobenzophenone derivatives. J. Braz. Chem. Soc., 2011, 22, 637-642.
16. Hansch, C. A quantitative approach to biochemical structureactivity relationships. Acc. Chem. Res., 1969, 2, 232-239.
17. Arthur, M. D. QSAR: dead or alive? J. Comput. Aided Mol. Des., 2008, 22, 81-89.
18. Ojha, P. K.; Mitra, I.; Das, R. N.; Roy, K. Further exploring rm 2 metrics for validation of QSPR models. Chemom. Intell. Lab. Syst., 2011, 107, 194-205.
19. Hameed, A. J.; Ibrahim, M.; ElHaes, H. Computational notes on structural, electronic and QSAR properties of Fulleropyrrolidine-1-carbodithioic acid 2;3 and 4-substituted-benzyl esters. J. Mol. Struct-THEOCHEM. 2007, 809, 131-136.
20. Essa, A. H.; Ibrahim, M.; Hameed, A. J.; Al-Masoudi, N. A. Theoretical investigation of 3'-subtituted-2'-3'-dideoxythymidines related to AZT. QSAR infrared and substituent electronic effect studies. ARKIVOC, 2008, xiii, 255-265.
21. Molecular Design Suite 3.5, VLife Technologies, Pune, India Available at wwwvlifesciencescom
22. Halgren, T. A. Merck molecular force field III: Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem., 1996, 17, 553-586.
23. Golbraikh, A.; Tropsha, A. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J. Comput-Aided Mol. Des., 2002, 16, 357-369.
24. Metropolis, N.; Rosenbluth, A. W.; Rosenbluth, M. N.; Teller, A. H. Equation of state calculations by fast computing machines. J. Chem. Phys., 1953, 21, 1087-1092.
25. Ajmani, S.; Jadhav, K.; Kulkarni, S. A. Three-Dimensional QSAR using the k-Nearest Neighbor method and its interpretation. J. Chem. Inf. Model., 2006, 46, 24-31.
26. Ghosh, P.; Bagchi, M. C. QSAR modeling for quinoxaline derivatives using genetic algorithm and simulated annealing based feature selection. Curr. Med. Chem., 2009, 16, 4032-4048.
27. Clark, M.; Cramer, R. D.; Van, O. N. Validation of the general purpose Tripose 5.2 force field. J. Comput. Chem., 1989, 10, 982-1012.
28. Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity-a rapid access to atomic charges. Tetrahedron, 1980, 36, 3219-3228.
29. Guyon, I.; Elisseeff, A. An introduction to variable and feature selection. J. Mach. Learning Res., 2003, 3, 1157-11820.
30. Darlington, R. B. Regression and Linear Models; McGraw-Hill: New York, 1990.
31. Zheng, W.; Tropsha, A. Novel variable selection quantitative structureproperty relationship approach based on the kNearest-Neighbor principle. J. Chem. Inf. Comput. Sci., 2000, 40, 185-194.
32. Shen, M.; Xiao, Y.; Golbraikh, A.; Gombar, V.; Tropsha, A. Development and validation of k-Nearest-Neighbor QSPR models of metabolic stability of drug candidates. J. Med. Chem., 2003, 46, 3013-3020.
33. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 1988, 110, 5959-5967.
34. Nandi, S.; Bagchi, M. C. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design. Mol. Divers., 2010, 14, 27-38.
35. Merckx, A.; Echalier, A.; Langford, K.; Sicard, A.; Langsley, G.; Joore, J.; Doerig, C.; Noble, M.; Endicott, J. Structure, 2008, 16, 228-238.
36. Samee, W.; Nunthanavanit, P.; Ungwitayatorn, J. 3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis. Int. J. Mol. Sci., 2008, 9, 235-246.